279 related articles for article (PubMed ID: 35833035)
1. Better Bioactivity, Cerebral Metabolism and Pharmacokinetics of Natural Medicine and Its Advanced Version.
Xie J; Zhong C; Wang T; He D; Lu L; Yang J; Yuan Z; Zhang J
Front Pharmacol; 2022; 13():937075. PubMed ID: 35833035
[TBL] [Abstract][Full Text] [Related]
2. Toward a better understanding of metabolic and pharmacokinetic characteristics of low-solubility, low-permeability natural medicines.
Yang J; Li K; He D; Gu J; Xu J; Xie J; Zhang M; Liu Y; Tan Q; Zhang J
Drug Metab Rev; 2020 Feb; 52(1):19-43. PubMed ID: 31984816
[TBL] [Abstract][Full Text] [Related]
3. Difference and alteration in pharmacokinetic and metabolic characteristics of low-solubility natural medicines.
Yan S; Liu Y; Feng J; Zhao H; Yu Z; Zhao J; Li Y; Zhang J
Drug Metab Rev; 2018 May; 50(2):140-160. PubMed ID: 29390894
[TBL] [Abstract][Full Text] [Related]
4. Metabolic pathways and pharmacokinetics of natural medicines with low permeability.
Zeng M; Yang L; He D; Li Y; Shi M; Zhang J
Drug Metab Rev; 2017 Nov; 49(4):464-476. PubMed ID: 28911247
[TBL] [Abstract][Full Text] [Related]
5. Insights into drug discovery from natural medicines using reverse pharmacokinetics.
Hao H; Zheng X; Wang G
Trends Pharmacol Sci; 2014 Apr; 35(4):168-77. PubMed ID: 24582872
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of nanomaterials in vivo: blood circulation and organ clearance.
Wang B; He X; Zhang Z; Zhao Y; Feng W
Acc Chem Res; 2013 Mar; 46(3):761-9. PubMed ID: 23964655
[TBL] [Abstract][Full Text] [Related]
7. A biomimetic zeolite-based nanoenzyme contributes to neuroprotection in the neurovascular unit after ischaemic stroke via efficient removal of zinc and ROS.
Huang Z; Qian K; Chen J; Qi Y; E Y; Liang J; Zhao L
Acta Biomater; 2022 May; 144():142-156. PubMed ID: 35296444
[TBL] [Abstract][Full Text] [Related]
8. Physical and biochemical insights on DNA structures in artificial and living systems.
Chen N; Li J; Song H; Chao J; Huang Q; Fan C
Acc Chem Res; 2014 Jun; 47(6):1720-30. PubMed ID: 24588263
[TBL] [Abstract][Full Text] [Related]
9. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
[TBL] [Abstract][Full Text] [Related]
10. Engineering of hybrid anticancer drug-loaded polymeric nanoparticles delivery system for the treatment and care of lung cancer therapy.
Zhao Y; Liu K; Li J; Liao J; Ma L
Drug Deliv; 2021 Dec; 28(1):1539-1547. PubMed ID: 34282705
[TBL] [Abstract][Full Text] [Related]
11. Quantification of carbon nanomaterials in vivo.
Wang H; Yang ST; Cao A; Liu Y
Acc Chem Res; 2013 Mar; 46(3):750-60. PubMed ID: 23035715
[TBL] [Abstract][Full Text] [Related]
12. Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.
Elliott RA; Tanajewski L; Gkountouras G; Avery AJ; Barber N; Mehta R; Boyd MJ; Latif A; Chuter A; Waring J
Pharmacoeconomics; 2017 Dec; 35(12):1237-1255. PubMed ID: 28776320
[TBL] [Abstract][Full Text] [Related]
13. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
[TBL] [Abstract][Full Text] [Related]
14. Effects of nanosuspension formulations on transport, pharmacokinetics, in vivo targeting and efficacy for poorly water-soluble drugs.
Wang Y; Miao X; Sun L; Song J; Bi C; Yang X; Zheng Y
Curr Pharm Des; 2014; 20(3):454-73. PubMed ID: 23651402
[TBL] [Abstract][Full Text] [Related]
15. Improving the Anti-Ovarian Cancer Activity of Docetaxel by Self-Assemble Micelles and Thermosensitive Hydrogel Drug Delivery System.
Xu G; Zhu C; Li B; Wang T; Wan J; Zhang Y; Huang J; Yang D; Shen Y
J Biomed Nanotechnol; 2020 Jan; 16(1):40-53. PubMed ID: 31996284
[TBL] [Abstract][Full Text] [Related]
16. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service.
Elliott RA; Boyd MJ; Salema NE; Davies J; Barber N; Mehta RL; Tanajewski L; Waring J; Latif A; Gkountouras G; Avery AJ; Chuter A; Craig C
BMJ Qual Saf; 2016 Oct; 25(10):747-58. PubMed ID: 26647412
[TBL] [Abstract][Full Text] [Related]
17. Nanosize drug delivery system.
Mukherjee B
Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
[TBL] [Abstract][Full Text] [Related]
18. Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity.
Wang A; Marinakos SM; Badireddy AR; Powers CM; Houck KA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):430-48. PubMed ID: 23661551
[TBL] [Abstract][Full Text] [Related]
19. [A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterial translocation--the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs--a review.
Kermanizadeh A; Balharry D; Wallin H; Loft S; Møller P
Crit Rev Toxicol; 2015; 45(10):837-72. PubMed ID: 26140391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
